Terminated PHASE4 INTERVENTIONAL NCT00130455

Treatment of Depression in the Elderly

A 12 Week Multi-Centre, Randomized, Double-Blind, Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients

Sponsor: Amager Hospital

Conditions Depression

Interventions escitalopram

Updated 5 times since 2017 Last updated: Feb 5, 2007 Started: Apr 30, 2006 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other Depression trials with similar outcome

Browse all Depression trials

This PHASE4 trial investigates Depression and is currently terminated or withdrawn. Amager Hospital leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amager Hospital
Geriatric Department,Korsør, Vestsjælland
Psychiatric Center Ballerup
Psychiatric Hospital, Hillerod
Psychogeriatric Unit, CU Hospital, Frederiksberg

Data source: Psychiatric Hospital, Hillerod

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hilleroed, Denmark